BMX and neuroblastoma: Consistent with the results obtained in our shRNA-mediated depletion experiments, BMX pharmacological inhibition by BMX-IN-1 resulted in a substantial reduction in spheroids viability (Figure 5D and Supplemental Figure 2D) and proliferation (Figure 5E) for both NB models.